Treatment of calcified coronary artery lesions

References

• Baber U, Kini AS, Sharma SK. Stenting of complex lesions: an overview. Nat Rev Cardiol. 2010;7(9):485–496.
   PubMed Web of Science ®Google Scholar
• Moussa I, Ellis SG, Jones M, et al. Impact of coronary culprit lesion calcium in patients undergoing paclitaxel-eluting stent implantation (a TAXUS-IV sub study). Am J Cardiol. 2005;96(9):1242–1247.
   PubMed Web of Science ®Google Scholar
• Kawaguchi R, Tsurugaya H, Hoshizaki H, et al. Impact of lesion calcification on clinical and angiographic outcome after sirolimus-eluting stent implantation in real-world patients. Cardiovasc Revasc Med. 2008;9(1):2–8.
   PubMedGoogle Scholar
• Fitzgerald PJ, Ports TA, Yock PG. Contribution of localized calcium deposits to dissection after angioplasty. An observational study using intravascular ultrasound. Circulation. 1992;86(1):64–70.
   PubMed Web of Science ®Google Scholar
• Moses JW, Carlier S, Moussa I. Lesion preparation prior to stenting. Rev Cardiovasc Med. 2004;5(Suppl 2):S16–S21.
   Google Scholar
• Ashikaga T, Yoshikawa S, Isobe M. The effectiveness of excimer laser coronary atherectomy with contrast medium for underexpanded stent: the findings of optical frequency domain imaging. Catheter Cardiovasc Interv. 2015;86(5):946–949.
   PubMed Web of Science ®Google Scholar
• Dangas GD, Claessen BE, Caixeta A, et al. In-stent restenosis in the drug-eluting stent era. J Am Coll Cardiol. 2010;56(23):1897–1907.
   PubMed Web of Science ®Google Scholar
• Fujii K, Carlier SG, Mintz GS, et al. Stent underexpansion and residual reference segment stenosis are related to stent thrombosis after sirolimus-eluting stent implantation: an intravascular ultrasound study. J Am Coll Cardiol. 2005;45(7):995–998.
   PubMed Web of Science ®Google Scholar
• Burzotta F, Trani C, Mazzari MA, et al. Use of a second buddy wire during percutaneous coronary interventions: a simple solution for some challenging situations. J Invasive Cardiol. 2005;17(3):171–174.
   PubMedGoogle Scholar
• Finet G, Weissman NJ, Mintz GS, et al. Mechanism of lumen enlargement with direct stenting versus predilatation stenting: influence of remodelling and plaque characteristics assessed by volumetric intracoronary ultrasound. Heart. 2003;89(1):84–90.
   PubMed Web of Science ®Google Scholar
• de Ribamar Costa J, Mintz GS, Carlier SG, et al. Nonrandomized comparison of coronary stenting under intravascular ultrasound guidance of direct stenting without predilation versus conventional predilation with a semi-compliant balloon versus predilation with a new scoring balloon. Am J Cardiol. 2007;100(5):812–817.
   PubMed Web of Science ®Google Scholar
• Takano M, Yamamoto M, Murakami D, et al. Optical coherence tomography after new scoring balloon angioplasty for in-stent restenosis and de novo coronary lesions. Int J Cardiol. 2010;141(3):e51–e53.
   Google Scholar
• Kanai T, Hiro T, Takayama T, et al. Three-dimensional visualization of scoring mechanism of ‘AngioSculpt’ balloon for calcified coronary lesions using optical coherence tomography. J Cardiol Cases. 2012;5:e16–e19.
   Google Scholar
• Okura H, Hayase M, Shimodozono S, et al. Mechanisms of acute lumen gain following cutting balloon angioplasty in calcified and noncalcified lesions: an intravascular ultrasound study. Catheter Cardiovasc Interv. 2002;57(4):429–436.
   PubMed Web of Science ®Google Scholar
• Kawase Y, Saito N, Watanabe S, et al. Utility of a scoring balloon for a severely calcified lesion: bench test and finite element analysis. Cardiovasc Interv Ther. 2014;29(2):134–139.
   PubMedGoogle Scholar
• Ashida K, Hayase T, Shinmura T. Efficacy of lacrosse NSE using the “leopard-crawl” technique on severely calcified lesions. J Invasive Cardiol. 2013;25(10):555–564.
   PubMed Web of Science ®Google Scholar
• Fernandez JP, Hobson AR, McKenzie DB, et al. How should I treat severe calcific coronary artery disease? EuroIntervention. 2011;7(3):400–407.
   PubMed Web of Science ®Google Scholar
• Badr S, Ben-Dor I, Dvir D, et al. The state of the excimer laser for coronary intervention in the drug-eluting stent era. Cardiovasc Revasc Med. 2013;14(2):93–98.
   PubMedGoogle Scholar
• Fernandez JP, Hobson AR, McKenzie D, et al. Beyond the balloon: excimer coronary laser atherectomy used alone or in combination with rotational atherectomy in the treatment of chronic total occlusions, non-crossable and non-expansible coronary lesions. EuroIntervention. 2013;9(2):243–250.
   PubMed Web of Science ®Google Scholar
• Nishino M, Lee Y, Nakamura D, et al. Differences in optical coherence tomographic findings and clinical outcomes between excimer laser and cutting balloon angioplasty for focal in-stent restenosis lesions. J Invasive Cardiol. 2012;24(10):478–483.
   PubMed Web of Science ®Google Scholar
• Latib A, Takagi K, Chizzola G, et al. Excimer Laser LEsion modification to expand non-dilatable stents: the ELLEMENT registry. Cardiovasc Revasc Med. 2014;15(1):8–12.
   PubMedGoogle Scholar
• Ebersole D, Dahm JB, Das T, et al. Excimer laser revascularization of saphenous vein grafts in acute myocardial infarction. J Invasive Cardiol. 2004;16(4):177–180.
   PubMedGoogle Scholar
• Azzalini L, Ly HQ. Laser atherectomy for balloon failure in chronic total occlusion. When the going gets tough. Int Heart J. 2014;55(6):546–549.
   PubMed Web of Science ®Google Scholar
• Kovach JA, Mintz GS, Pichard AD, et al. Sequential intravascular ultrasound characterization of the mechanisms of rotational atherectomy and adjunct balloon angioplasty. J Am Coll Cardiol. 1993;22(4):1024–1032.
   PubMed Web of Science ®Google Scholar
• Bersin RM, Simonton CA. Rotational and directional coronary atherectomy. Catheter Cardiovasc Interv. 2003;58(4):485–499.
   PubMed Web of Science ®Google Scholar
• Tomey MI, Kini AS, Sharma SK. Current status of rotational atherectomy. JACC Cardiovasc Interv. 2014;7(4):345–353.
   PubMed Web of Science ®Google Scholar
• Bangalore S, Vlachos HA, Selzer F, et al. Percutaneous coronary intervention of moderate to severe calcified coronary lesions: insights from the national heart, lung, and blood institute dynamic registry. Catheter Cardiovasc Interv. 2011;77(1):22–28.
   PubMed Web of Science ®Google Scholar
• Safian RD, Feldman T, Muller DW, et al. Coronary angioplasty and rotablator atherectomy trial (CARAT): immediate and late results of a prospective multicenter randomized trial. Catheter Cardiovasc Interv. 2001;53(2):213–220.
   PubMed Web of Science ®Google Scholar
• Whitlow P, Bass T, Kipperman R, et al. Results of the study to determine rotablator and transluminal angioplasty strategy (STRATAS). Am J Cardiol. 2001;87(6):699–705.
   PubMed Web of Science ®Google Scholar
• Cavusoglu E, Kini AS, Marmur JD, et al. Current status of rotational atherectomy. Catheter Cardiovasc Interv. 2004;62(4):485–498.
   PubMed Web of Science ®Google Scholar
• Agostoni P, Biondi-Zoccai GG, de Benedictis ML, et al. Radial versus femoral approach for percutaneous coronary diagnostic and interventional procedures; Systematic overview and meta-analysis of randomized trials. J Am Coll Cardiol. 2004;44(2):349–356.
   PubMed Web of Science ®Google Scholar
• Rao SV, Ou FS, Wang TY, et al. Trends in the prevalence and outcomes of radial and femoral approaches to percutaneous coronary intervention: a report from the national cardiovascular data registry. JACC Cardiovasc Interv. 2008;1(4):379–386.
   PubMed Web of Science ®Google Scholar
• Watt J, Oldroyd KG. Radial versus femoral approach for high-speed rotational atherectomy. Catheter Cardiovasc Interv. 2009;74(4):550–554.
   PubMed Web of Science ®Google Scholar
• From AM, Gulati R, Prasad A, et al. Sheathless transradial intervention using standard guide catheters. Catheter Cardiovasc Interv. 2010;76(7):911–916.
   PubMed Web of Science ®Google Scholar
• Mamas M, D’Souza S, Hendry C, et al. Use of the sheathless guide catheter during routine transradial percutaneous coronary intervention: a feasibility study. Catheter Cardiovasc Interv. 2010;75(4):596–602.
   PubMed Web of Science ®Google Scholar
• Kassimis G, Patel N, Kharbanda RK, et al. High-speed rotational atherectomy using the radial artery approach and a sheathless guide: a single-centre comparison with the “conventional” femoral approach. EuroIntervention. 2014;10(6):694–699.
   PubMed Web of Science ®Google Scholar
• Dunn B. The effects of debulking on restenosis (EDRES). J Saudi Heart Assoc. 1998;10:55.
   Google Scholar
• Buchbinder M, Fortuna R, Sharma S, et al. Debulking prior to stenting improves acute outcomes: early results from the SPORT trial. J Am Coll Cardiol. 2000;35(2):8A.
   Google Scholar
• Abdel-Wahab M, Richardt G, Joachim Büttner H, et al. High-speed rotational atherectomy before paclitaxel-eluting stent implantation in complex calcified coronary lesions: the randomized ROTAXUS (rotational atherectomy prior to taxus stent treatment for complex native coronary artery disease) trial. JACC Cardiovasc Interv. 2013;6(1):10–19.
   PubMed Web of Science ®Google Scholar
• Cockburn J, Hildick-Smith D, Cotton J, et al. Contemporary clinical outcomes of patients treated with or without rotational coronary atherectomy–an analysis of the UK central cardiac audit database. Int J Cardiol. 2014;170(3):381–387.
   PubMed Web of Science ®Google Scholar
• Cortese B, Aranzulla TC, Godino C, et al. Drug-eluting stent use after coronary atherectomy: results from a multicentre experience - The ROTALINK I study. J Cardiovasc Med (Hagerstown). 2015 Jan 7. PubMed PMID: 25575276 [Epub ahead of print].
   Google Scholar
• Yabushita H, Takagi K, Tahara S, et al. Impact of rotational atherectomy on heavily calcified, unprotected left main disease. Circ J. 2014;78(8):1867–1872.
   PubMed Web of Science ®Google Scholar
• Schwartz BG, Mayeda GS, Economides C, et al. Rotational atherectomy in the drug-eluting stent era: a single-center experience. J Invasive Cardiol. 2011;23(4):133–139.
   PubMed Web of Science ®Google Scholar
• Benezet J, Díaz de la Llera LS, Cubero JM, et al. Drug-eluting stents following rotational atherectomy for heavily calcified coronary lesions: long-term clinical outcomes. J Invasive Cardiol. 2011;23(1):28–32.
   PubMed Web of Science ®Google Scholar
• Kubota T, Ishikawa T, Nakano Y, et al. Retrospective comparison of clinical and angiographic outcomes after sirolimus-eluting and bare-metal stent implantation in 312 consecutive, nonrandomized severely calcified lesions using a rotablator. Int Heart J. 2011;52(2):65–71.
   PubMed Web of Science ®Google Scholar
• Rathore S, Matsuo H, Terashima M, et al. Rotational atherectomy for fibro-calcific coronary artery disease in drug eluting stent era: procedural outcomes and angiographic follow-up results. Catheter Cardiovasc Interv. 2010;75(6):919–927.
   PubMed Web of Science ®Google Scholar
• Mezilis N, Dardas P, Ninios V, et al. Rotablation in the drug eluting era: immediate and long-term results from a single center experience. J Interv Cardiol. 2010;23(3):249–253.
   PubMed Web of Science ®Google Scholar
• Vaquerizo B, Serra A, Miranda F, et al. Aggressive plaque modification with rotational atherectomy and/or cutting balloon before drug-eluting stent implantation for the treatment of calcified coronary lesions. J Interv Cardiol. 2010;23(3):240–248.
   PubMed Web of Science ®Google Scholar
• Furuichi S, Sangiorgi GM, Godino C, et al. Rotational atherectomy followed by drug-eluting stent implantation in calcified coronary lesions. EuroIntervention. 2009;5(3):370–374.
   PubMed Web of Science ®Google Scholar
• Kini A, Reich D, Marmur JD, et al. Reduction in periprocedural enzyme elevation by abciximab after rotational atherectomy of type B2 lesions: results of the Rota ReoPro randomized trial. Am Heart J. 2001;142(6):965–969.
   PubMed Web of Science ®Google Scholar
• Sharma SK, Dangas G, Mehran R, et al. Risk factors for the development of slow flow during rotational coronary atherectomy. Am J Cardiol. 1997;80(2):219–222.
   PubMed Web of Science ®Google Scholar
• Lincoff AM, Bittl JA, Harrington RA, et al. Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial. JAMA. 2003;289(7):853–863.
   PubMed Web of Science ®Google Scholar
• Stone GW, White HD, Ohman EM, et al. Bivalirudin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a subgroup analysis from the acute catheterization and urgent intervention triage strategy (ACUITY) trial. Lancet. 2007;369(9565):907–919.
   PubMed Web of Science ®Google Scholar
• Steg PG, Van ‘T Hof A, Hamm CW, et al. Bivalirudin started during emergency transport for primary PCI. N Engl J Med. 2013;369(23):2207–2217.
   PubMed Web of Science ®Google Scholar
• Akin I, Khattab AA, Büttner HJ, et al. Comparison of bivalirudin and heparin in patients undergoing rotational atherectomy: a subanalysis of the randomised ROTAXUS trial. EuroIntervention. 2014;10(4):458–465.
   PubMed Web of Science ®Google Scholar
• Wasiak J, Law J, Watson P, et al. Percutaneous transluminal rotational atherectomy for coronary artery disease. Cochrane Database Syst Rev. 2012;12:CD003334.
   Google Scholar
• Braden G, Bailey R, Fitzgerald D, et al. Mechanisms of bradyarrhythmias associated with rotational atherectomy. J Am Coll Cardiol. 1996;27(2s1):168.
   Google Scholar
• Colombo A, Panoulas VF. After 3 decades, at long last, a new device to deal with calcific lesions. JACC Cardiovasc Interv. 2014;7(5):519–520.
   PubMed Web of Science ®Google Scholar
• Chambers JW, Diage T. Evaluation of the diamondback 360 coronary orbital atherectomy system for treating de novo, severely calcified lesions. Expert Rev Med Devices. 2014;11(5):457–466.
   PubMed Web of Science ®Google Scholar
• Parikh K, Chandra P, Choksi N, et al. Safety and feasibility of orbital atherectomy for the treatment of calcified coronary lesions: the ORBIT I trial. Catheter Cardiovasc Interv. 2013;81(7):1134–1139.
   PubMed Web of Science ®Google Scholar
• Bhatt P, Parikh P, Patel A, et al. Orbital atherectomy system in treating calcified coronary lesions: 3-Year follow-up in first human use study (ORBIT I trial). Cardiovasc Revasc Med. 2014;15(4):204–208.
   PubMedGoogle Scholar
• Bhatt P, Parikh P, Patel A, et al. Long-term safety and performance of the orbital atherectomy system for treating calcified coronary artery lesions: 5-Year follow-up in the ORBIT I trial. Cardiovasc Revasc Med. 2015;16(4):213–216.
   PubMedGoogle Scholar
• Chambers JW, Feldman RL, Himmelstein SI, et al. Pivotal trial to evaluate the safety and efficacy of the orbital atherectomy system in treating de novo, severely calcified coronary lesions (ORBIT II). JACC Cardiovasc Interv. 2014;7(5):510–518.
   PubMed Web of Science ®Google Scholar
• Généreux P, Lee AC, Kim CY, et al. Orbital atherectomy for treating de novo severely calcified coronary narrowing (1-Year Results from the Pivotal ORBIT II Trial). Am J Cardiol. 2015;115(12):1685–1690.
   Web of Science ®Google Scholar
• Warth DC, Leon MB, O’Neill W, et al. Rotational atherectomy multicenter registry: acute results, complications and 6-month angiographic follow-up in 709 patients. J Am Coll Cardiol. 1994;24(3):641–648.
   PubMed Web of Science ®Google Scholar
• MacIsaac AI, Bass TA, Buchbinder M, et al. High speed rotational atherectomy: outcome in calcified and noncalcified coronary artery lesions. J Am Coll Cardiol. 1995;26(3):731–736.
   PubMed Web of Science ®Google Scholar
• Kini AS, Vengrenyuk Y, Pena J, et al. Optical coherence tomography assessment of the mechanistic effects of rotational and orbital atherectomy in severely calcified coronary lesions. Catheter Cardiovasc Interv. 2015;86(6):1024–1032.
   PubMed Web of Science ®Google Scholar